MARLBOROUGH, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter. On a per-share basis, the Marlborough, ...

Akoya Biosciences Inc (NASDAQ:AKYA) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 ...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report) will announce its earnings results after the market closes on Thursday, ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology (IO) and ...

Akoya Biosciences (AKYA) will unveil innovations designed to accelerate insights in immuno-oncology, IO, and advance preclinical research at ...

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Akoya Biosciences (AKYA – Research Report). The ...

Investing.com - Akoya Biosciences (NASDAQ: AKYA) reported second quarter EPS of $-0.51, $0.07 worse than the analyst estimate of $-0.44. Revenue for the quarter came in at ...

Akoya Biosciences. "With this new offering, we’re extending the impact of spatial biology in critical stages of drug development, providing the tools to explore key biological insights early in ...

Featured here, the Balance Sheet for Akoya Biosciences Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology ...